Join to View Full Profile
4500 San Pablo Road SJacksonville, FL 32224
Dr. Advani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2012 - 2015
University at BuffaloResidency, Internal Medicine, 2009 - 2012
Dr. DY Patil Medical CollegeClass of 2007
Certifications & Licensure
FL State Medical License 2012 - 2026
GA State Medical License 2024 - 2025
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Cryotherapy for the Prevention of Taxane-Induced Sensory Neuropathy of the Hands and Feet in Breast Cancer Patients Start of enrollment: 2020 Mar 10
- A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer Start of enrollment: 2022 Mar 07
Roles: Contact, Principal Investigator
- Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation Start of enrollment: 2023 Oct 31
Roles: Contact
Publications & Presentations
PubMed
- Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic Experience.Nusrat Jahan, Jodi Taraba, Nicholas J Boddicker, Karthik V Giridhar, Roberto A Leon-Ferre
Clinical Breast Cancer. 2025-04-01 - QIM25-237: Supporting Oncologists in Capturing and Using Structured Oncology Data in Real-Time Using the Electronic Health Record (EHR).Amye J Tevaarwerk, Clare Gatten, Teshome Simret, Karthik Giridhar, Jamie Carroll
Journal of the National Comprehensive Cancer Network. 2025-03-28 - Pembrolizumab in combination with binimetinib in patients with unresectable locally advanced or metastatic triple-negative breast cancer.Saranya Chumsri, Joseph J Larson, Emily Liu, Kathleen S Tenner, Daniel Adams
Clinical Cancer Research. 2025-03-07
Press Mentions
Immune Checkpoint Inhibitors: Immunotherapy for People with Triple-Negative Breast CancerDecember 27th, 2022- Mayo Clinic Q and a: Immunotherapy and Breast CancerOctober 8th, 2021
- Mayo Clinic Research in the News — 2/22/2021February 22nd, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
